Insider Transactions in Q1 2021 at Resmed Inc (RSMDF)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Indirect |
1,081
-0.51%
|
$199,985
$185.48 P/Share
|
Mar 10
2021
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.5%
|
$462,500
$185.0 P/Share
|
Mar 03
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,487
-1.12%
|
$284,017
$191.8 P/Share
|
Mar 01
2021
|
Rajwant Sodhi President, SaaS Business |
SELL
Open market or private sale
|
Direct |
1,500
-4.53%
|
$291,000
$194.34 P/Share
|
Feb 19
2021
|
Ronald R Taylor Director |
SELL
Open market or private sale
|
Direct |
4,000
-17.57%
|
$800,000
$200.14 P/Share
|
Feb 16
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Indirect |
998
-0.47%
|
$199,600
$200.46 P/Share
|
Feb 10
2021
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.44%
|
$502,500
$201.37 P/Share
|
Feb 03
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,487
-1.11%
|
$303,348
$204.42 P/Share
|
Feb 01
2021
|
Rajwant Sodhi President, SaaS Business |
SELL
Open market or private sale
|
Direct |
1,500
-4.34%
|
$304,500
$203.76 P/Share
|
Feb 01
2021
|
James Hollingshead President, Sleep Business |
SELL
Open market or private sale
|
Direct |
2,400
-2.66%
|
$480,000
$200.18 P/Share
|
Jan 18
2021
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,014
+1.7%
|
-
|
Jan 18
2021
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
4,099
+19.71%
|
-
|
Jan 18
2021
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,822
+1.75%
|
-
|
Jan 18
2021
|
James Hollingshead President, Sleep Business |
BUY
Grant, award, or other acquisition
|
Direct |
1,913
+2.08%
|
-
|
Jan 18
2021
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,548
+1.14%
|
-
|
Jan 18
2021
|
Rajwant Sodhi President, SaaS Business |
BUY
Grant, award, or other acquisition
|
Direct |
1,913
+5.24%
|
-
|
Jan 18
2021
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
865
+2.22%
|
-
|
Jan 15
2021
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Indirect |
938
-0.44%
|
$198,856
$212.86 P/Share
|
Jan 11
2021
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.42%
|
$545,000
$218.7 P/Share
|
Jan 04
2021
|
Rajwant Sodhi President, SaaS Business |
SELL
Open market or private sale
|
Direct |
1,500
-4.39%
|
$319,500
$213.24 P/Share
|
Jan 04
2021
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,487
-1.11%
|
$316,731
$213.24 P/Share
|
Jan 04
2021
|
James Hollingshead President, Sleep Business |
SELL
Open market or private sale
|
Direct |
2,400
-2.65%
|
$506,400
$211.09 P/Share
|